BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17728268)

  • 41. A shorter interval between menarche and first sexual intercourse is associated with increased risk of high-grade cervical disease.
    Smith JS
    Evid Based Nurs; 2014 Jan; 17(1):6-7. PubMed ID: 23708400
    [No Abstract]   [Full Text] [Related]  

  • 42. [Papillomavirus and cervical carcinoma].
    Launay O
    Med Sci (Paris); 2008 Nov; 24(11):981-2. PubMed ID: 19038104
    [No Abstract]   [Full Text] [Related]  

  • 43. EUROGIN 2007 patient education conference: sharing experiences and action in cervical cancer prevention--an overview. Part 2.
    Pagliusi S; Lawson H; Singer A; Monsonego J
    Vaccine; 2008 Mar; 26 Suppl 1():A33-6. PubMed ID: 18642460
    [No Abstract]   [Full Text] [Related]  

  • 44. Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.
    Jackson CH; Jit M; Sharples LD; De Angelis D
    Med Decis Making; 2015 Feb; 35(2):148-61. PubMed ID: 23886677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human breast cancer and sexual activities.
    Akil N; Kassab A; Yasmeen A; Darnel AD; Bismar TA; Al Moustafa AE
    Br J Cancer; 2008 Jan; 98(2):508-9; author reply 510-11. PubMed ID: 18219293
    [No Abstract]   [Full Text] [Related]  

  • 46. Loops in the natural history of cervical cancer.
    Petry KU
    Lancet Oncol; 2011 Oct; 12(11):986. PubMed ID: 21917521
    [No Abstract]   [Full Text] [Related]  

  • 47. Intrauterine device and cervical cancer: we need more evidence.
    Lopez-del Burgo C; Osorio A; De Irala J
    Lancet Oncol; 2011 Dec; 12(13):1185-6; author reply 1186-7. PubMed ID: 22123595
    [No Abstract]   [Full Text] [Related]  

  • 48. Cancer epidemiology. Part III. Cervical cancer.
    Buchanan-Davidson D
    Wis Med J; 1978 Aug; 77(8):17 contd. PubMed ID: 695688
    [No Abstract]   [Full Text] [Related]  

  • 49. [Morbidity of cervical and uterine cancer in the Republic of Armenia].
    Adamian RT
    Vopr Onkol; 2001; 47(5):562-5. PubMed ID: 11785096
    [No Abstract]   [Full Text] [Related]  

  • 50. Nonidentifiability in Model Calibration and Implications for Medical Decision Making.
    Alarid-Escudero F; MacLehose RF; Peralta Y; Kuntz KM; Enns EA
    Med Decis Making; 2018 Oct; 38(7):810-821. PubMed ID: 30248276
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
    Ultsch B; Damm O; Beutels P; Bilcke J; Brüggenjürgen B; Gerber-Grote A; Greiner W; Hanquet G; Hutubessy R; Jit M; Knol M; von Kries R; Kuhlmann A; Levy-Bruhl D; Perleth M; Postma M; Salo H; Siebert U; Wasem J; Wichmann O
    Pharmacoeconomics; 2016 Mar; 34(3):227-44. PubMed ID: 26477039
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complexity in mathematical models of public health policies: a guide for consumers of models.
    Basu S; Andrews J
    PLoS Med; 2013 Oct; 10(10):e1001540. PubMed ID: 24204214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets.
    Basu S; Chapman GB; Galvani AP
    Proc Natl Acad Sci U S A; 2008 Dec; 105(48):19018-23. PubMed ID: 19015536
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE; Unger ER; Saraiya M
    J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
    [No Abstract]   [Full Text] [Related]  

  • 55. Human papillomavirus genotype distributions inform screening and vaccination policy.
    Pinkowish MD
    CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300
    [No Abstract]   [Full Text] [Related]  

  • 56. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.
    Giuliano AR; Salmon D
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):805-8. PubMed ID: 18398020
    [No Abstract]   [Full Text] [Related]  

  • 57. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
    Brotherton JM
    Vaccine; 2008 Jan; 26(2):250-6. PubMed ID: 18068276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
    Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
    Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re: "Multiparameter calibration of a natural history model of cervical cancer".
    Basu S; Galvani AP
    Am J Epidemiol; 2007 Oct; 166(8):983; author reply 983-4. PubMed ID: 17728268
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.